Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice.

J. Satoh, Hiroaki Seino, T Abo, +7

Journal of Clinical Investigation

InflammationCytokineAutoimmune DiseaseMedicineDiabetes +12

Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double‐blind, placebo‐controlled trial

J. Satoh, Soroku Yagihashi, Masayuki Baba, +4

Diabetic Medicine

Functional properties of the stratum corneum in patients with diabetes mellitus: similarities to senile xerosis

Shingo Sakai, Kenji Kikuchi, J. Satoh, +2

British Journal of Dermatology

Inhibition of development of peripheral neuropathy in streptozotocin-induced diabetic rats with N-acetylcysteine

Mikio Sagara, J. Satoh, Ryuichi Wada, +6

Diabetologia

Peripheral NeuropathyMedicinePhysiologyDiabetesDiabetic Neuropathy +8

Autoantibodies against CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) that impair glucose-induced insulin secretion in noninsulin- dependent diabetes patients.

Fumiko Ikehata, J. Satoh, Koji Nata, +8

Journal of Clinical Investigation

ImmunologyGlycobiologyCadpr LevelsInsulin SignalingMetabolic Syndrome +14

Role of urotensin II gene in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects

Susumu Suzuki, M. Hirai, Yoshinori Hinokio, +4

Diabetologia

Metabolic SyndromeUrologyGenetic DeterminantUrotensin Ii GeneGenetics +6

Inhibition of type 1 diabetes in BB rats with recombinant human tumor necrosis factor-alpha.

J. Satoh, Hiroaki Seino, S Shintani, +5

The Journal of Immunology

Tnf InducerHtnf-alpha-treated RatsImmunologyPathologyInsulin Signaling +15

Inhibitory effect of troglitazone on diabetic neuropathy in streptozotocin-induced diabetic rats

Xiaoling Qiang, J. Satoh, Mikio Sagara, +7

Diabetologia

MedicineDiabetesDiabetic NeuropathyNeuropharmacologyPharmacotherapy +4

Psychosocial factors are independent risk factors for the development of Type 2 diabetes in Japanese workers with impaired fasting glucose and/or impaired glucose tolerance¹

Makiko Toshihiro, Koh Saito, S. Takikawa, +3

Diabetic Medicine

N-acetylcysteine inhibits loss of diaphragm function in streptozotocin-treated rats.

Wataru Hida, Chiyohiko Shindoh, J. Satoh, +4

American Journal of Respiratory and Critical Care Medicine

Molecular PharmacologyMetabolic SyndromeMolecular PhysiologyDiaphragm FunctionMedicine +13